Is EHC undervalued or overvalued?
As of 2025-03-26, the Intrinsic Value of Encompass Health Corp (EHC) is 110.80 USD. This EHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 100.87 USD, the upside of Encompass Health Corp is 9.80%. This means that EHC is undervalued by 9.80%.
The range of the Intrinsic Value is 79.38 - 175.25 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 79.38 - 175.25 | 110.80 | 9.8% |
| DCF (Growth 10y) | 115.44 - 236.96 | 155.53 | 54.2% |
| DCF (EBITDA 5y) | 78.20 - 125.86 | 95.00 | -5.8% |
| DCF (EBITDA 10y) | 109.85 - 169.97 | 131.46 | 30.3% |
| Fair Value | 44.02 - 44.02 | 44.02 | -56.36% |
| P/E | 103.50 - 110.55 | 107.03 | 6.1% |
| EV/EBITDA | 40.92 - 104.76 | 62.78 | -37.8% |
| EPV | 100.46 - 136.06 | 118.26 | 17.2% |
| DDM - Stable | 36.12 - 92.02 | 64.07 | -36.5% |
| DDM - Multi | 68.90 - 136.52 | 91.59 | -9.2% |
| Market Cap (mil) | 10,158.62 |
| Beta | 0.67 |
| Outstanding shares (mil) | 100.71 |
| Enterprise Value (mil) | 10,158.62 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.60% |
| Cost of Debt | 5.13% |
| WACC | 7.66% |